Physician profile
Jeffry L Jacobs
NPI 1134169279
$3,934.63
in general payments reported to CMS, 2019-2025
12 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Surgery of The Hand (Plastic Surgery) provider received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $121 · 2021: $397 · 2023: $2,730 · 2024: $305 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,779 · Food and Beverage: $919 · Long Term Medical Supply Or Device Loan: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,778.75 |
| Food and Beverage | $918.85 |
| Long Term Medical Supply Or Device Loan | $487.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alafair Biosciences, INC. | $2,078.75 | 2023 | Versawrap |
| Integra Lifesciences Corporation | $835.63 | 2021-2023 | Acell |
| Axogen | $290.77 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Acera Surgical, INC. | $150.00 | 2025 | Restrata Wound Matrix |
| Abbvie INC. | $140.00 | 2023 | |
| Allergan, INC. | $125.00 | 2019 | |
| Pfizer INC. | $107.24 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $103.97 | 2020 | |
| Boston Scientific Corporation | $37.28 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $27.91 | 2021 | |
| Medtronic, INC. | $24.08 | 2023 | Minimed 770g |
| Pacira Pharmaceuticals Incorporated | $14.00 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffry Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.